The Federal Trade Commission and the State of Maine are seeking a civil contempt order against two companies that market dietary supplements, alleging they have continued to promote their products using unproven claims that they can treat and cure diseases, in violation of a 2018 FTC settlement order. The agencies’ contempt motion states that Health Research […]
Tag Archives: Bureau of Consumer Protection Consumer Protection Advertising and Marketing Health Claims
FTC Sends Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases, Including Cancer, Alzheimer’s, and Multiple Sclerosis
As part of its regular monitoring of health-related advertising claims, the Federal Trade Commission today sent warning letters to three companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol (CBD), a chemical compound derived from the cannabis plant. The letters warn the companies, which the FTC is not identifying publicly, that it is […]
FTC Joins FDA in Sending Warning Letters to Companies Advertising and Selling Products Containing Cannabidiol (CBD) Claiming to Treat Alzheimer’s, Cancer, and Other Diseases
As part of its ongoing efforts to ensure that dietary supplements and other health-related products are advertised truthfully, and that efficacy claims made for such products are supported by competent and reliable scientific evidence, the Federal Trade Commission joined the U.S. Food and Drug Administration (FDA) in sending warning letters to three companies marketing products […]
“Nobetes” Dietary Supplement Marketers Settle FTC Complaint Alleging Unsubstantiated Health Claims, Illegal Billing Practices, and Deceptive Endorsements
The officers of a company that marketed and sold Nobetes, a pill they claimed treats diabetes, have settled a Federal Trade Commission complaint alleging that the advertising claims for the product are false or unsubstantiated. The order settling the FTC’s complaint prohibits the company and its officers from undertaking future deceptive practices, including making unsubstantiated […]
At FTC’s Request, Court Stops False Advertising and Unauthorized Billing Scheme
At the Federal Trade Commission’s request, a federal district court in California has temporarily halted a company’s advertising of three dissolvable oral film strips that the Commission alleges were deceptively marketed as effective smoking cessation, weight-loss, and sexual-performance aids. The court has also temporarily halted the company from enrolling consumers in any auto-ship continuity plan […]
FTC Approves Final Consent Order in Aromaflage Insect Repellent Advertising Case
Following a public comment period, the Federal Trade Commission has approved a final consent order settling deceptive advertising charges against Mikey & Momo, Inc. and its owners regarding the marketing of their Aromaflage sprays and candles. According to the FTC’s complaint, the New Jersey-based company and its owners used deceptive claims to sell perfume sprays […]
Court Rules in FTC’s Favor in Case against Weight-loss Supplement Marketer Roca Labs
A U.S. district court in Florida has granted the Federal Trade Commission’s motion for summary judgment on all counts of its amended complaint against weight-loss supplement marketer Roca Labs, including allegations that the company’s enforcement of “gag clauses” to stop consumers from posting negative reviews is unfair and likely to cause substantial harm, in violation […]
FTC Halts Deceptive Mosquito-Repellent Claims for Aromaflage Perfume and Candles
A New Jersey-based company and its owners have agreed to settle Federal Trade Commission charges that they used deceptive claims to sell purportedly mosquito-repelling perfume sprays and scented candles. The FTC contends the company’s efficacy claims for its Aromaflage products – marketed as “fragrance with function” – are not supported by scientific evidence, and that […]
FTC Settlement Turns Down the Volume on Deceptive Sound Amplifier Ads
A set of Florida-based entities and their owner are settling Federal Trade Commission charges that advertisements for their MSA 30X sound amplifier deceptively claimed the device is “independently tested to help you hear up to 30 times better.” Under a court order settling the FTC’s complaint, the defendants will be barred from making similar unsupported […]
FTC Approves Final Consent Order in Telomerase Activation Sciences Deceptive Advertising Case
Following a public comment period, the Federal Trade Commission has approved a final consent order settling deceptive advertising charges against Telomerase Activation Sciences, Inc. and Noel Patton (collectively, TA Sciences). According to the FTC’s February 2018 complaint, TA Sciences lacked the scientific evidence to support claims that its capsules, powder, and cream could provide a […]